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Abstract  
Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease that affects the 
central nervous system. Cardiovascular function (CV) has been shown to be impaired in persons 
with MS which can lead to the development of comorbidities that can promote disability 
progression. Cardiorespiratory fitness (CRF) and, to a lesser extent, muscular fitness (MF) have 
been shown to improve CV function in healthy populations. This thesis examined the 
relationships between CRF, MF, and exercise presented by randomized controlled trials via 
meta-analysis. Then, the relationships between CRF, MF, and CV function in persons with MS 
was determined in order to determine targets for therapy that might improve CV function. 
Results suggest exercise training improved CRF and MF in RCTs of exercise training examining 
CRF and MF outcomes. Further, the results of this cross-sectional study indicate significant 
relationships exist between CRF, MF and CV function in persons with MS. These studies 
support the potential to improve physiological fitness through exercise training as a possible 
means to improve CV function in persons with MS. This might be accomplished through 
exercise training interventions involving aerobic and/or resistance exercise.   
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Chapter 1 
Review of the literature 
1.1 Introduction and background 
  Multiple sclerosis (MS) is an immune-mediated neurodegenerative disease that affects 
the central nervous system (CNS) and can eventually cause disability. MS has prevalence of 
about 58 of every 100,000 persons in the U.S. Current estimates by the National MS Society 
estimate the total number of persons living in the U.S. with MS to be above 400,000.1   MS is 
occurring at a rate of about 200 new cases each week in the U.S. More cases tend to be 
diagnosed north of the equator, especially in Europe and North America. In the U.S., a difference 
in diagnoses rates between those who live above the 37th parallel when compared to than those 
who live below it can be observed. Those who live above the 37th parallel develop MS at a 
higher rate, approximately 110-140 cases per 100,000 people, while those living below the 37th 
parallel develop MS at a lower rate, approximately 57-78 cases per 100,000 people. 
Underdiagnoses of MS has also been suggested, and would result in a lower estimated 
prevalence. This could be due to the similarities between symptoms of MS symptoms and other 
neurological diseases such as Alzheimer’s and Parkinson’s diseases.  
   There are genetic and environmental risk factors that influence the development of MS. 
Gender plays a large factor in risk of MS development with 2.3-3.5 women being diagnosed  for 
every one male diagnoses.2 This is thought to be caused by different expression of genes between 
men and women, well as differences in the response to environmental factors that could play a 
role in the etiology of MS. Race is another factor that influences the risk of MS and is also 
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genetically determined.3 A higher prevalence for disease occurrence has be proposed to occur in 
North American descended whites, but this has been contested by other studies suggesting that 
American blacks have a higher prevalence.4 Along with these genetic factors, an individual’s 
environment is also largely a predictor for developing MS. Geographical latitude is related to 
risk of developing MS. The prevalence of the disease is higher in the more northern latitude 
countries, although an argument could be made that these are largely western countries and have 
better diagnostic procedures in place. Lower levels of vitamin D have been suggested to be 
related to risk for MS.4  The theory of vitamin D’s influence on risk of MS relates to exposure to 
sunlight which is dependent on geographical location. However, MS does not occur at the same 
rate in geographical areas in the southern hemisphere that receive similar amounts of sunlight as 
higher locations in the northern hemisphere. Along with sunlight based vitamin D, ingestion of 
vitamin D has also be proposed as being influential in MS development. Other prominent 
environmental factors include infection (Epstein barr virus) and smoking. Higher antibody levels 
for the Epstein-Barr virus have been correlated with increased risk of developing MS. A similar 
case has been made for increased risk in persons who have been infected with mononucleosis.3 
Although these theories are possible, a causal link between these infections and MS has yet to be 
determined. Lastly, smoking has been shown to be related to MS risk although again this a 
correlative relationship. Genetics and environmental factors are two key factors that determine 
risk of developing MS.  
 MS is both an inflammatory and neurodegenerative disease affecting the CNS. Although 
the culmination of these factors initiate a varied pattern of lesion development and subsequent 
symptom development, progression of the disease eventually follows a similar course toward a 
neurodegenerative state. Initial stages of the disease involve inflammatory attacks that target 
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neurons, perhaps due to the development of an anti-myelin antibody that the body has begun to 
genetically express. These inflammatory attacks lead to histologic trademark damage in the 
myelin sheath and surrounding oligodendrocytes. The myelin sheath is responsible for expediting 
the electrical current that travels from neuron to neuron. Oligodendrocytes are responsible for the 
development of myelin and its repair. The damage in these two structures prevents optimal signal 
propagation within the CNS. As inflammatory attacks persist, axonal damage becomes 
seemingly irreversible. Over time, inflammatory episodes lessen and immunoglobulins can be 
seen, while separated myelin continues to be surrounded and destroyed by immune cells. This 
state of chronic neuronal injury is seen in those that have usually had MS for a longer period of 
time.5 
 The pathogenesis of the disease is classified into four types/courses of MS. The most 
common course is relapsing remitting MS (RRMS), of which 85% are initially diagnosed with. 
RRMS is characterized by episodic inflammatory attacks that are known as exacerbations or 
relapses.6 During these relapses, the patient can be under a great deal of disability. A relapse is 
defined as a new neurologic symptom lasting for more than 24 hours that has no other 
explanation.7 Criteria for relapse involve: (1) Signs of inflammation and demyelination presented 
through testing or progression of disability; (2) The relapse lasts over 24 hours; (3) The relapse is 
separated by at least 30 days from a previous relapse; and (4) The relapse is not related to stress, 
fever or infection. The periods of relapse can have lasting damage on the structure and signaling 
potential of neurons, as well as functional and symptomatic implications. Remissions are periods 
between relapses in which symptoms can improve, sometimes completely. These relapses are 
commonly treated with different steroid treatments which have been shown to decrease the acute 
impact of relapses.8 Over time, the course of MS can transition. Most people initially diagnosed 
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with RRMS will eventually transition to secondary progressive MS (SPMS).6 SPMS is different 
from the RRMS because relapses and high inflammation is not as prevalent, but disease 
progression steadily continues. Two other types/courses of MS also exist. The Primary 
progressive multiple sclerosis (PPMS) course involves disease progression that is similar to 
SPMS, but occurs from the onset of the disease.6 Persons with PPMS have no relapses and have  
lower basal inflammation that is more common in SPMS. Lesions are also more prevalent within 
the spinal cord of persons with PPMS as compared to those with RRMS. PPMS involves a 
steady and continuous increase in disease progression as opposed to the off and on progression 
seen with RRMS. About 10% of persons with MS have PPMS at disease onset according to the 
National MS Society. The fourth type of MS is also the least prevalent with only 5% of 
diagnoses. Progressive-relapsing MS (PRMS) involves a progression similar to PPMS in that a 
steady disease progression is always occurring, but there are also relapses occurring.6 Like 
RRMS and PPMS, PRMS is diagnosed at disease onset.  
 The general measure of disability in MS is the Expanded Disability Status Scale (EDSS). 
The EDSS is a scale that ranges from 0 (no disability) to 10 (death) that seeks to identify 
disability through assessments involving visual, brainstem, pyramidal, cerebellar, sensory, bowel 
and bladder, and cerebral function as well as ambulation. 0 to 3.0 on the EDSS indicates minimal 
disability. Patients in this range do not have musculoskeletal impairments, but may have other 
symptomology that is prevalent. The range of 3.0 to < 6.0 is considered moderate disability. Gait 
impairment and ambulatory dysfunction occurs in this range, but no assistive device is necessary. 
The range of 6.0 to 9.5 is considered severe disability. In this range different disability scores are 
given largely based on the use of ambulatory devices for assistance including unilateral 
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assistance (6.0), bilateral assistance (6.5), or  wheelchair (7.0) with scores >7.0 associated with 
bed rest.  
 
1.2 Disability and Physical Activity in MS  
The accumulation of disability has profound effects on the daily lives of people with MS. 
Impaired CNS signaling has a direct impact on musculoskeletal function and results in lower 
activity levels in persons with MS. A cycle of deconditioning begins with the onset of MS 
leading to physical inactivity and subsequently physiological deconditioning.9 A relationship 
exists between deconditioning and disability that accompanies disease progression.10 Physical 
inactivity is not only an issue in clinical populations like MS. According to the CDC’s 2014 
report on physical activity in the U.S., only about 20% of Americans are achieving the 150 
minute a week recommendation for moderate aerobic exercise and muscular strengthening 
guidelines. The implications have been clear as lower levels of physical activity are associated 
with higher rates of CVD, obesity, metabolic disease, and all-cause mortality. The case is similar 
in MS. Historically, persons with MS have been told to refrain from too much physical activity 
(PA) and to be easy on themselves physically. A meta-analysis on PA in MS found that persons 
with MS participate much less PA than healthy people. In the same study, the authors found 
persons with MS do not differ in PA levels compared to other clinical populations (chronic 
fatigue syndrome, chronic obstructive pulmonary disease, cerebral palsy). As with increased risk 
of CVD and metabolically related disease in the healthy populations, persons with MS can have 
a similarly increased risk of developing these diseases which can impact their disease.11,12 PA in 
MS is also related to type/course of MS. People with PPMS tend to have lower levels of PA 
when compared to those suffering from RRMS. People with PPMS tend to have more severe 
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symptoms, a higher disability level overall, less mobility, and are less likely to engage in PA. 
This can directly interfere with day to day function or  participation in physical activity.13 Even 
with the consistency of these findings, PA among persons with MS varies from person to person 
and can be affected by other lifestyle choices.      
1.3 Physical Fitness 
 Cardiorespiratory fitness reflects the body’s ability for delivering, extracting, and using 
oxygen for prolonged endurance exercise and is typically measured as peak aerobic capacity 
(VO2peak), peak power output (Wp), and anaerobic or lactate threshold (l/mmol). Muscular fitness 
reflects the body’s ability for generating and maintaining muscular force via skeletal muscle 
contraction and is commonly measured as muscular strength (e.g., peak force) and endurance 
(e.g., maximum repetitions). Higher rates of fitness have been associated with improved all-
cause mortality in non-diseased populations. Specifically, improved physical fitness has been 
shown to associate with lower rates of death from CVD and cancer.14 This is a clear indicator 
that along with regular physical activity, good physical fitness is conducive to a healthy lifestyle 
and better longevity. When concerning MS, a disease that is associated with low PA, low fitness, 
and a more sedentary lifestyles physical fitness is often ignored as a component of health, not 
being seen as a potential factor for improving functionality in MS. 
 Physical fitness has two main components for the sake of this discussion: 
cardiorespiratory and muscular. Cardiorespiratory fitness (CRF) reflects the body’s ability for 
delivering, extracting, and utilizing oxygen for endurance exercise and is typically measured as 
peak aerobic capacity (VO2peak), peak power output (Wp), and anaerobic or lactate threshold 
(l/mmol).15  CRF has individually been associated with better overall mortality rates, CVD, 
metabolic syndrome, diabetes, and cancer in healthy people.16,14,17,18 Because of its strong 
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relationship with improved health outcomes, CRF has become an integral component in a 
multidisciplinary approach to health in medicine. Augmentation of CRF is possible through 
exercise intervention involving aerobic exercise which can be conducted via many modalities 
such as running, biking, rowing, swimming, etc. Increases in VO2peak occur even with lower 
intensity aerobic exercise and continue to increase in a dose-dependent manner with increasing 
intensity and duration of aerobic exercise.19 These changes also can result in better insulin 
sensitivity, decreases in fat mass, and markers of inflammation, and plasma triglycerides.20,21 
Clearly, aerobic exercise has become a well-established medical therapy for many issues 
especially in chronic disease prevention and treatment.  
1.4 Physical Fitness in MS: Muscular Fitness 
 Muscular fitness (MF) reflects the body’s ability for generating and maintaining muscular 
force via skeletal muscle contraction and is commonly measured as muscular strength (e.g., peak 
force) and endurance (e.g., maximum repetitions). MF has also been associated with better health 
outcomes, albeit not as robustly as CRF. MF has been found to be inversely related to all-cause 
mortality and cancer in men after adjusting for CRF.22,23 MF has also been shown to be 
associated with better risk factor analyses for metabolic syndrome, osteoporosis, diabetes, and 
CVD in healthy people.24,25,26,27,28,29,30,31,32,33,34. This means the risk factors, or physiological 
measures that have been known to increase risk of one of these diseases are found less in persons 
with improved MF. These findings illustrate the importance of MF in both healthy, older, and 
clinical populations. Research on the effects of improved MF in these populations through 
different types of resistance exercise training. Resistance training is defined as the act of repeated 
voluntary muscle contractions against a resistance greater than those normally encountered in 
activities of daily living.35 Through this form of training three main changes affecting 
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performance can be observed: hypertrophy, strength, and endurance. Hypertrophy refers to 
changes in morphology in musculature in which muscle fibers grow in diameter. Strength 
changes are commonly assessed as peak torque and reflect neuromuscular adaptations involving 
motor recruitment as well as hypertrophy. Endurance refers to the capacity to achieve multiple 
repetitions of a given weight and reflects the muscles ability to delay neural and intramuscular 
fatigue. These changes facilitate the aforementioned metabolic, functional, and clinically 
relevant benefits of MF. The case has been resoundingly made for the potential of resistance 
training to affect MF and be of possible benefit to health outcomes involving cardiovascular and 
musculoskeletal function in healthy and clinical populations alike.   
1.5 Physical Fitness in MS: Cardiorespiratory Fitness 
 When compared to healthy controls, persons with MS have been found to have worse 
CRF. In one study, CRF, based on VO2peak, was 28% higher in a sample of 25 healthy controls 
compared to 25 participants with MS.36 In another study, 32 persons with MS were found to have 
roughly 12% decreased relative VO2peak compared to 16 healthy controls. MF shares a similar 
case. For example, one study of 15 participants with MS and 15 healthy controls demonstrated 
that persons with MS had significantly lower peak torque production in the nondominant knee 
extensors, dominant knee flexors, and nondominant knee flexors compared to healthy controls.37 
Another study found persons with MS to have significantly worse isokinetic strength in the knee 
extensors during the eccentric and concentric phases of contraction when compared to healthy 
controls.38 As previously described, a cycle of deconditioning is present in persons with MS and 
this is only further promoted as disease progression, relapse, increases in symptomology, or 
complications due to comorbidity occur. The physical inactivity that is spurred on by the onset of 
MS is an important factor in the physiological deconditioning seen in MS. Even the light 
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stimulus provided by daily PA on the cardiorespiratory and muscular systems can promote 
maintenance of current musculature and function. Persons with MS often encounter a spiral 
downward in their functionality. This is due to deconditioning from MS progression that leads to 
less likelihood of PA and eventually a loss of function. Fortunately, exercise physiologists have 
been examining the effects of exercise on persons with MS and current literature suggests a 
potential reversal of the downward spiral caused by inactivity and physiological deconditioning. 
After all, the body of a person with MS is still under the same principles of physiology regarding 
exercise and fitness.   
1.6 Exercise Training and Physical Fitness in MS 
 Both exercise with the intent of improving CRF and MF has been studied in MS. A 
recent review of 54 studies of varying quality found the current evidence to suggest that exercise 
training is effective for improving both CRF and MF in persons with MS. Further, this review 
suggested exercise may be beneficial to mobility, fatigue, and health related quality of life. 
Twelve studies of varying quality suggested changes in aerobic capacity following exercise 
training. The authors concluded that a frequency of 2-3 bouts of exercise a week at 60% or more 
VO2peak will elicit adaptations in CRF. Further, peak power output was shown to improve 
following aerobic exercise in 6 studies as well. The effect of combined modality (aerobic and 
resistance training) has also been shown to positively affect peak power although there is less 
evidence regarding this.39 There is also evidence for increases in MF following exercise training 
in MS. The same review examined evidence from 6 randomized controlled trials and found 8-20 
weeks of supervised resistance training performed 2-3 times a week at moderate intensity 
increased MF. There are established benefits to improving CRF in both clinical and non-clinical 
populations alike. CRF in particular is important for maintaining cardiovascular health, body 
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composition, and physical function and in a population that can be impaired in these health 
qualities it is imperative to provide novel therapies to augment them. The benefits of improving 
MF in persons with MS are also well established. MF improvements have been associated with 
improved walking speed and endurance, gait outcomes, cognition, and fatigue in MS.40 It can be 
concluded that, with regular exercise, fitness in persons with MS can be improved. These 
improvements in CRF and MF help to facilitate further secondary benefits in persons with MS 
that encompass each realm of disability that can be seen in MS. Through review and meta-
analyses a quantifiable effect on CRF and MF can be expected suggesting exercise as a therapy 
in this clinical population is nothing to overlook when considering the benefits of improved 
fitness. 
Other Benefits of Exercise Training in MS   Exercise also have benefits to persons with MS that 
do not directly related to fitness improvements. But exercise among persons with MS is not 
common. A study that surveyed 2,995 veterans that had MS found only about 28% of them to 
self-report doing any regular exercise41. Even though few people with MS participate in regular 
exercise there are a number of studies that have looked at mental health, quality of life, mobility 
and gait, and components of health in MS following regular exercise. A number of randomized 
controlled trials have examined the effects of exercise on depressive symptoms in MS. Out of the 
13 studies that did so 11 were found to have positive effects on depression symptoms. A meta-
analyses of the effects of exercise on MS was conducted and quantified the effect of exercise on 
depression in these studies. The authors found an effect of 1/3 SD or ES = 0.36 suggesting a 
small magnitude change in depressive symptoms can be expected following regular exercise 
training for persons with MS.42 This is supported by meta-analyses that demonstrate a favorable 
effect of exercise on depression in healthy and clinically depressed persons that do not have 
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MS.43,44,45,46. Depression or depressive symptoms are common in MS. An estimated 50% of 
patients with MS become depressed or develop depressive symptoms over the duration of their 
MS. Because of the complicated nature of MS disease pathology within the CNS and 
depression’s neurological basis, treating depression in MS patients can be difficult due to drug 
interactions and disability affecting accessibility to therapists. These studies suggest exercise 
may be an alternative means to help with these depressive symptoms in MS.  
 The effect of exercise on quality of life has also been examined in persons with MS. 
Quality of life considers one’s subjective interpretation of components of their life’s that they 
deem important such as psychological, social, and physical well-being. Evidence suggests that 
persons with MS can have compromised quality of life.47 This may be due to the nature of 
having a progressive disease of which there is not yet a cure available. A meta-analyses 
examined the available literature involving the effects of exercise on quality of life in persons 
with MS.  Out of high quality studies 13 studies examined, 12 showed positive effects of 
exercise on quality of life in MS. Overall, the authors found an effect of approximately ¼ SD or 
SE=0.23 suggesting a small magnitude change in quality of life can be expected following 
regular exercise training in persons with MS.48 The conclusion that exercise can help provide a 
small effect to quality of life is important in a clinical population like MS. Again patients are 
shown to be more predisposed to depression and to have a negative outlook on their own lives 
which can be affected by having a progression disease such as MS. Exercise is a behavior that 
can added to one’s lifestyle and has numerous established benefits. Along with those health 
benefits, the possibilities of improving one’s outlook on life can have real impact of further 
behavior and positivity which can lead to better outcomes.49 
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 Mobility and gait have also been shown to improve following exercise training in persons 
with MS. The progression of MS is synonymous with the development of gait impairments and 
further disruptions to mobility. These impairments culminate disability that often results in the 
need for ambulatory devices such as canes, walkers, and wheelchairs. The effect loosing mobility 
capability can be profound as it demotes incentives to move decreasing PA. Nearly half of those 
diagnosed with MS with be in need of an ambulatory device within 15 to 25 years of diagnoses. 
Further 9 out of every 10 persons with MS with have severe disability leaving them with even 
larger mobility limitations. Since mobility is largely used as an identifier of disease progression 
it is a target for treatment either indirectly through disease-modifying medications or directly 
through exercise intervention. In another meta-analyses the effect of exercise interventions on 
mobility outcomes in MS was quantified. 22 high-quality studies were included in the analysis. 
All but 3 of the included studies showed a beneficial effect of exercise on walking mobility. The 
overall effect size indicated that walking mobility improved 1/5 SD in persons with MS 
following exercise training. The overall effect size (ES) was g=0.19. The effect was more 
pronounced when controlling for supervision of exercise training with an ES of g=0.32 
suggesting more improvements can be seen regarding walking mobility when people are 
supervised throughout their exercise regimen. It is clear that exercise training has effects on the 
musculoskeletal system of clinical and non-clinical populations alike. Both aerobic and 
resistance training can elicits these benefits in the musculoskeletal system leading to improved 
mobility, gait, and function. These improvements in turn can spur motivation to be more 
improving PA which would in turn help maintain these functions. 
1.7 Cardiovascular Function in MS   
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CV function involves circulatory and autonomic function related to the heart, as well their 
responsiveness to stimulus or return to homeostasis. This is also affected by morphological 
components of arteries such as arterial stiffness, compliance of the blood vessel, and heart 
function. Importantly, such cardiovascular dysfunction can contribute to risk of developing 
vascular comorbidities and CVD in MS, which are associated with MS disease progression.10  
 Arterial function has been shown to be compromised in persons with MS. Arterial 
function describes measures such as blood flow, arterial stiffness, arterial wave reflection, and 
morphological changes like intima media thickness. The collection of these measures provides a 
multifactorial view of arterial function and are considered subclinical indicators of 
atherosclerosis and a compromised cardiovascular system. One cross sectional study compared 
arterial function in 33 MS patients to 33 healthy controls. The authors found arterial function to 
be significantly different in persons with MS compared to healthy controls. Particularly, peak 
forearm blood flow, pulse wave velocity (a measure of arterial stiffness), and arterial compliance 
were all significantly lower in the MS group. The authors also measured markers of 
inflammation since persons with MS can have chronically elevated levels of these markers and 
they can be responsible for cardiovascular challenge and further dysfunction. Inflammatory 
markers were not found to be elevated in the MS group compared to the healthy controls; 
therefore, arterial dysfunction is occurring in absence of chronically elevated inflammation.50 
This supports the notion that MS is also a vascular disease due to its effects on endothelial 
function.  
 Additionally, person with MS are known to develop compromised autonomic nervous 
systems leading to symptoms involving cardiovascular function, bowel and bladder function, 
sexual dysfunction, fatigue, sleep and others. In the cardiovascular system, autonomic disruption 
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stemming from demyelination of the CNS in MS results in issues related to heart rate variability 
and blood pressure variability. Previous studies have found a raised sympathetic tone in persons 
with MS.51 Further, persons with MS have decreased heart rate variability and decreased blood 
pressure response. These issues can be a consequence of the development of brain lesions that 
are occur during MS disease progression.52 In one study examining autonomic function in MS, 
researchers recorded heart rate variability in deep breathing examinations and heart rate and 
blood pressure responses in a tilt table test. Cardiovascular response was found to correlate with 
MS disease disability and number of brain lesions.52 This is supported by the progression of 
autonomic cardiovascular dysfunction in MS following a one year follow up.53 The effects of 
disease progression on autonomic function and its subsequent cardiovascular dysfunction help to 
further develop the cardiovascular profile of MS patients and provide avenues for potential 
intervention. Since autonomic nervous system issues are commonplace in MS the effects of 
lesion load on autonomic nervous system functions, especially cardiovascular responses, remains 
a topic for research and potential intervention. 
Vascular Comorbidities in MS   Vascular comorbidity can include hypercholesterolemia, 
hypertension, heart disease, diabetes, and peripheral vascular disease. Many people have 
multiple vascular comorbidities in addition to MS, further exacerbating their risk profile. A 
review found even one vascular comorbidity can increase the rate of progression in MS disability 
if it is present at the onset of MS. Those with one vascular comorbidity at onset were ultimately 
found to have a 50% increased risk of ambulatory disability throughout the course of their MS. 
The same review found a dose-response relationship between the number of vascular 
comorbidities and the speed of disability progression in persons with MS. Persons with MS 
suffering from two vascular comorbidities are at 228% risk of developing gait disability.10 With 
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this information in mind, treating comorbid conditions in persons with MS has the potential to 
diminish disability progression, particularly ambulatory function.  
 Persons with MS have been found to have a greater risk of CVD. In one example, a large 
cohort study involving 8000 participants, researchers examined the risk of myocardial infarction, 
heart failure, stroke, and atrial fibrillation or flutter in patients diagnosed with MS.54 The authors 
found a significantly greater risk for CVD in persons with MS. Specifically, relative risk of 
myocardial infarction, stroke, and heart failure were 1.85, 1.71, and 1.97 times more likely in 
persons with MS. The authors proposed several factors contributing to this including immune 
dysfunction and elevated inflammation but also included suggestions that homocysteine, 
decreased arterial function, oxidative stress, cerebral hypoperfusion, and even therapeutic use of 
glucocorticoids all can affect the risk for development of CVD. The end result of these factors 
and the development of CVD can expectedly increase the mortality of those with MS. Therefore, 
addressing the components of cardiovascular health is imperative for helping persons with MS 
maintain function and improve mortality.  
 The aforementioned evidence paints a stark picture of the cardiovascular profile of person 
with MS. As disease progression occurs and further disability accumulates a decrease in PA can 
also be expected without direct intervention. A compromised cardiovascular system coupled with 
the effects of deconditioning are important consideration for clinicians responsible for treating 
MS. Neglecting cardiovascular health has obvious detrimental effects on health in non-clinical 
populations who have no disability issues let alone MS. MS patients and their clinicians should 
be fully aware of the challenges presented in cardiovascular health that can accompany MS. 
Interventions for increasing cardiovascular health are also of interest in MS. Aerobic exercise has 
extensive support as an intervention for maintaining and improving all components of one’s 
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cardiovascular profile. The results of aerobic exercise on MS have been previously mentioned 
here but again provide a means to counteract the negative cardiovascular issues that can arise in 
MS.  
1.8 Purpose and Rationale 
 Physiological fitness and cardiovascular health are two components that have potential to 
be augmented by exercise and benefit persons with MS. Exercise training is a potential 
intervention to augment both of these components in persons with MS (since it has a large body 
of evidence to support its effects on physiological fitness and cardiovascular function in healthy 
people). It is important to determine whether or not exercise training can be associated with 
improvement in physiological fitness which includes cardiorespiratory and muscular fitness in 
persons with MS. Current evidence from higher quality studies, randomized controlled trials, of 
exercise training effects on physiological fitness in MS are promising but suffer from being 
examined in individually resulting in conclusions drawn from smaller sample sizes and possibly 
failing to determine effects of exercise interventions. When examining these studies, a systematic 
quantification of the effects of exercise on fitness is necessary to determine an overall effect of 
exercise training interventions on physiological fitness. For this reason, a meta-analysis was used 
to quantify the effect of exercise interventions on cardiorespiratory and muscular fitness 
outcomes in persons with MS. The result of this analyses will provide an indication of the 
magnitude of effect one could expect from implementing an exercise training program in this 
population. The hypothesis considered was that exercise training would be associated with 
improvements in muscular and cardiorespiratory fitness outcomes and these improvements 
would be moderate in magnitude.  
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 The relationships between MS, physiological fitness, and CV function are in need of 
further evidence. Although evidence suggests an impaired cardiovascular profile among persons 
with MS, more studies are needed to corroborate these deficits in MS. However, cardiovascular 
improvements have yet to be studied in this population. Since cardiovascular function is strongly 
related to CRF and is also associated with muscular fitness to a lesser degree in healthy 
populations it is important to examine the relationship between physiological fitness and 
cardiovascular function in MS. For this reason a cross-sectional study was used to examine these 
relationships among in patients with MS. It was hypothesized that physiological fitness will be 
associated with all components of cardiovascular function and arterial function. This study will 
provide insight into the relationship between fitness and cardiovascular function in MS helping 
identify better targets for therapy to promote better cardiovascular health and a better disease risk 
profile in persons with MS.  
 The purpose of this thesis is to provide evidence about the relationships between MS, 
physiological fitness, and CV function. To examine this, (1) a meta-analysis will be conducted to 
systematically quantify current research literature that used exercise as an intervention in MS. 
This will provide information regarding the magnitude of effect that can be expected if a person 
with MS engages in regular exercise training. Both CRF and MF will be examined to determine 
the effect of exercise on them individually. To examine the relationship between physiological 
fitness and CV function in persons with MS (2) a cross-sectional analysis will be conducted 
using validated measures of CV function and gold standard measures of fitness. The overall 
benefit of these studies will be to provide evidence for clinicians to make educated, evidence-
based recommendations when developing exercise programs for persons with MS that concern 
fitness and CV function. 
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Chapter 2 
The effect of exercise training on fitness in multiple sclerosis: A meta-analysis 
Matthew Platta, Ipek Ensari, Robert W Motl, Lara A Pilutti 
 
2.1 Introduction 
 Multiple sclerosis (MS) is a neurological disease characterized by inflammatory attacks 
within the central nervous system that result in axonal demyelination and transection as well as 
neurodegeneration.1 The pathophysiological processes associated with the disease result in 
impairments in various domains including walking, cognition, and symptomatic changes such as 
depression and fatigue. The consequences of MS further compromise participation in physical 
activity and this results in significant detraining (i.e., physiological deconditioning), particularly 
in the domains of muscular and cardiorespiratory fitness.2 Muscular fitness reflects the body’s 
ability for generating and maintaining muscular force via skeletal muscle contraction and is 
commonly measured as muscular strength (e.g., peak force) and endurance (e.g., maximum 
repetitions). Cardiorespiratory fitness reflects the body’s ability for delivering, extracting, and 
using oxygen for prolonged endurance exercise and is typically measured as peak aerobic 
capacity (VO2peak), peak power output (Wp), and anaerobic or lactate threshold (l/mmol). The 
maintenance of muscular and cardiorespiratory fitness is critical for preserving and restoring 
physical functioning and participation among persons with MS.3 
There is evidence that both muscular and cardiorespiratory fitness are impaired in persons 
with MS. For example, one study of 15 participants with MS and 15 healthy controls 
demonstrated that persons with MS had significantly lower peak torque production in the 
nondominant knee extensors, dominant knee flexors, and nondominant knee flexors compared to 
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healthy controls.4 This has been replicated in other studies.5,6 Similarly, cardiorespiratory fitness, 
based on VO2peak, was 28% higher in a sample of 25 healthy controls compared to 25 participants 
with MS, and such deficits have been replicated in other studies.5,7,8 The detraining and loss of 
fitness in persons with MS combined with the importance of physiological fitness for functional 
and symptomatic outcomes underscores the importance of developing and evaluating the 
efficacy of interventions that target indices of muscular and cardiorespiratory fitness.   
 Exercise training probably reflects the intervention modality with the best likelihood and 
relevance for improving physiological fitness in persons with MS. There is evidence for the 
benefits of resistance and aerobic training for improving physiological fitness in persons with 
MS.9-11  For example, one systematic review reported that 8-20 weeks of moderate intensity (i.e., 
10-12 repetitions @ 70-80% 1RM) resistance training performed 2 to 3 times per week increased 
muscular strength in persons with MS; there were insufficient data for demonstrating a change in 
muscular endurance.12 That review further reported that moderate intensity (i.e., 60-80% Wp or 
60% VO2peak) aerobic exercise training, 2 to 3 times a week for 30 to 60 minutes increased 
cardiorespiratory fitness (VO2peak) in persons with MS.
12   
Those data are promising, but have important limitations that can be overcome in a meta-
analysis. The studies often suffer from small sample sizes resulting in non-significant effects 
resulting in the possible interpretation of no consistent or definitive effect of exercise training on 
fitness. The studies and literature review do not provide an indication of the magnitude of 
improvement in fitness outcomes following exercise training that can be provided through meta-
analysis. Such an indication of magnitude is important for clinical research and practice by 
providing an evidence-based estimate of the actual benefit that exercise training may confer on 
physiological fitness. It is further note that there is likely variability in the effect of exercise 
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training on fitness adaptations, and this can be quantified using moderator analysis in meta-
analysis. This will be important for indicating the characteristics of exercise or the sample that 
maximize the improvement in fitness outcomes. There are further examples of the value of meta-
analysis for providing additional insight into the effect of exercise training on outcomes in MS 
that were not possible in literature reviews.13,14 
 We undertook a meta-analysis for providing a quantitative assessment of the effect of 
exercise training on muscular and cardiorespiratory fitness outcomes in persons with MS. To do 
this, we conducted a systematic and comprehensive meta-analysis of published randomized 
controlled trials (RCTs) involving exercise training and MS that included outcomes of muscular 
and cardiorespiratory fitness. We hypothesized exercise training to be associated with 
improvements in muscular and cardiorespiratory fitness outcomes and these improvements 
would be moderate in magnitude as fitness is a more proximal outcome of exercise training than 
other outcomes (e.g., walking and quality of life) included in meta-analyses of exercise training 
in MS.14-17 
 
2.2 Methods 
 This meta-analysis was conducted consistent with the Meta-analysis of Observational 
Studies in Epidemiology (MOOSE) framework, and a visual description of these step-by-step 
methods is provided in Figure 1.18 We conducted a search of the following electronic databases: 
PubMed, Web of Science and Google Scholar, using the keywords “exercise” OR “aerobic” OR 
“strength” OR “resistance training” OR “cardiorespiratory” AND “multiple sclerosis”. We 
included RCTs that were published up to October 2014. We initially retrieved 1501 articles of 
which 1439 were excluded for the following reasons: duplicates, review articles and no inclusion 
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of persons with MS. We further searched the bibliographies of the retrieved articles and 
reviewed a total of 62 articles in detail. Of these articles, there were 42 without an objective 
fitness outcome measure, exercise training manipulation, appropriate control group, or 
randomization, and these studies were excluded. If the papers did not include sufficient 
information for calculating effect sizes (ES), we contacted the authors for further information. 
We included RCTs (i.e., studies that compared exercise training vs. no-treatment control and 
stated assigning participants to conditions randomly) that administered measures of physical 
fitness (e.g., VO2peak, isokinetic strength) pre-post intervention. We excluded RCTs that did not 
include persons with MS, an appropriate objective fitness outcome, or an appropriate exercise 
training intervention. This resulted in a total of 20 RCTs that were included in the meta-
analysis.7,9,11,19-36 
  We computed Ess expressed as Cohen’s d.37 To do this, we computed the mean change 
from before to after exercise training and subtracted the mean change of the control condition. 
The resulting difference in mean change between the conditions was then divided by the baseline 
standard deviation (SD) pooled between conditions. The Ess were calculated so that a positive 
ES indicated an improvement in fitness levels after exercise training, whereas a negative ES 
indicated a worsening of fitness levels in the exercise condition compared with control. Separate 
Ess were calculated per dependent variable (i.e., some studies had multiple fitness outcomes) as 
well as per type of exercise (i.e., some studies had more than one type of exercise training 
modality or condition). The overall analysis took place using a single ES per study (i.e., an 
average ES when there was more than one ES computed by the software). This was necessary as 
multiple Ess from the same study are not independent.38 The lack of independence can bias the 
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standard error (SE) for judging the significance of the overall ES and multiple Ess from one 
study bias the overall ES disproportionately compared with the studies that have a single ES.38  
 The Ess along with the associated standard errors (Ses) were entered into the 
Comprehensive Meta-analysis Software (Version 2.0, Biostat, Englewood, New Jersey). The 
analyses were conducted separately for the muscular and cardiorespiratory fitness outcomes. We 
used a random-effects model for computing the overall or mean ES (for each fitness outcome) as 
this model assumes that the samples come from populations with different Ess and that the true 
effect differs between studies.38 We further computed a 95% confidence interval (CI) around the 
mean ES. An overall Q value and I2 value were calculated to test for homogeneity of variance 
among Ess. The Q value is a measure of variance among the Ess and a statistically significant 
(p < .05) sum of the squares of each ES about the weighted mean (Q) indicates heterogeneity. 
The I2 value represents the magnitude of the heterogeneity where a larger number indicates 
larger heterogeneity. 
 We further performed separate post-hoc, exploratory moderator analyses using a random-
effects model to partition any possible homogeneity within the 2 overall Ess for muscular and 
cardiorespiratory outcomes. Under the random-effects model, it is assumed that the ES 
heterogeneity is due to unobserved, random sources and is recommended as the preferred 
strategy due to the generality of this model.39 We sought to apply this model as it is a more 
robust approach and to avoid potentially underestimating the variation between studies. The 
moderator analyses for muscular outcomes were based on the categorical variables of type of 
outcome measure (muscular strength vs. endurance), type of measurement device (isokinetic vs. 
other), training progression (progression over time vs. no progression), sample size (40 or fewer 
vs. more than 40 participants) and supervision (supervised training vs. partially or unsupervised 
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training). The moderator analyses for cardiorespiratory outcomes were based on the categorical 
variables of type of cardiorespiratory outcome measure (VO2peak vs. Wp vs. other), type of 
exercise training (aerobic vs. other), exercise modality (cycle ergometer vs. other), exercise 
intensity (moderate vs. high based on the American College of Sport Medicine Guidelines for 
Exercise Testing and Prescription), sample size (fewer than 25 vs. 25 or more participants), and 
supervision (supervised training vs. partially or unsupervised training).40 The selected 
moderators were categorized, in part, based on the number of studies available within each 
category (at least 3 studies per category) and upon initial reactions regarding possible effect 
moderators. Each study was used as the unit of analysis (averaging the Ess within each study in 
the case of multiple subgroups per study) when conducting the moderator analyses, except where 
noted (See Tables 2 and 3). The Ess per subgroup were coded separately (i.e., without averaging 
all subgroup Ess per study) in two cases to allow for comparisons of the categories within the 
moderator variable. This occurred with respect to the moderator variables type of muscular 
outcome measure in studies by Medina-Perez et al and Broekmann et al and, and the moderator 
variable of supervision in the study by Cakit et al.21,26,27 
 The quality of the studies included in the meta-analysis was established using the 11-item 
Physiotherapy Evidence Database (PEDro) scale for RCTs.41,42 This scale has previously been 
used in reviews of exercise training in MS.12,43 As recommended by the PEDro scoring 
guidelines, item 1 was not included when computing the overall score; therefore, total scores on 
the PEDro ranged between 0 and 10.41 Higher scores on the PEDro indicate better 
methodological quality. 
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2.3 Results 
 Table 1 provides the sample and exercise characteristics per study, along with the PEDro 
scores. Overall, 62 Ess were retrieved from the 20 published RCTs that included a total of 722 
persons with MS. Figures 2 and 3 provide visual descriptions of the average ES per study for 
muscular and cardiorespiratory fitness outcomes, respectively.  
 The distribution of Ess for muscular outcomes had slight positive skewness (g1=1.05, 
SE=.60) and kurtosis (g2=.88, SE=1.15). Eleven of the 14 Ess from the studies were greater than 
zero (i.e., 79%). The funnel plot of the average Ess from the 14 studies suggested against 
publication bias. The overall weighted mean ES was 0.27 (SE=0.05, 95% CI=0.17-0.38, z=5.05, 
p<.001). This reflects a statistically significant and small effect in favor of exercise training for 
improving muscular fitness compared with the control condition. The weighted mean ES was not 
heterogeneous (Q=11.09, df=13, p=.60, I²=0.00). This indicates that the variation among studies 
was not greater than expected due to random chance.  
 The distribution of Ess for cardiorespiratory fitness had slight negative skewness (g1=-
1.46, SE=.69) and significant positive kurtosis (g2=3.023, SE=1.33). Nine of the 10 Ess from the 
studies were greater than zero (i.e., 90%). The funnel plot of the average Ess from the 10 studies 
suggested against publication bias. The overall weighted mean ES was 0.47 (SE=0.09, 95% 
CI=0.30-0.65, z=5.40, p<.001). This reflects a statistically significant and moderate effect in 
favor of exercise training for improving cardiorespiratory fitness compared with the control 
condition. The weighted mean ES was not heterogeneous (Q=7.83, df=9, p=0.55, I²=0.00). This 
indicates that the variation among studies was not greater than expected due to random chance. 
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Moderator analyses 
The lack of heterogeneity in the overall analyses indicated minimal variation in Ess 
across the RCTs, yet we still conducted exploratory, post-hoc analyses using categorical 
moderator variables for possibly informing future research. Point estimates, Ses and significance 
values for the Qb statistic are provided in Tables 2 and 3 for muscular and cardiorespiratory 
fitness outcomes, respectively. For muscular fitness outcomes, the additional analyses identified 
the type of muscular outcome measure as a possible moderator variable (p=.05) (see Table 2), 
indicating an effect in favor of muscular compared to cardiorespiratory outcomes. In the 
cardiorespiratory fitness analysis, the moderator variable of supervision approached statistical 
significance (p=0.06). The presence of exercise supervision was associated with greater 
improvements in cardiorespiratory fitness outcomes than conditions that had no or minimal 
supervision. However, the results of this moderator analyses should be interpreted with caution 
due to the uneven and small number of Ess per category. 
 
Clinical meaningfulness 
We estimated the possible clinical meaningfulness of the overall Ess by determining the 
degree of improvement in fitness outcomes using mean scores and SDs from a recent publication 
of persons with MS.44 We first estimated the amount of change in fitness outcomes by 
multiplying the overall Ess with the SDs for VO2peak, (SD = 7.25) and peak knee extensor and 
flexor torque (Nm, SDs = 52.41 and 24.75, respectively). This indicated that aerobic exercise 
training resulted in an increase in VO2peak of 3.41 ml/kg/min, whereas resistance exercise resulted 
in an increase of peak extensor and flexor torque of 14.15 and 6.69 Nms, respectively. We then 
determined the percent change in fitness outcomes by dividing the amount of change in fitness 
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outcomes by the respective mean values for VO2peak (M = 19.26) and peak knee extensor and 
flexor torque (M = 149.15 and 57.50, respectively). This resulted in a 17.7% change in VO2peak 
as a consequence of exercise training, and a 9.5% change in extensor strength and 11.6% change 
in knee flexor strength as a result of exercise training. The calculated percent change for 
cardiorespiratory fitness clearly exceeded the threshold value of a 10% change in VO2peak that 
has been deemed clinically relevant.45 
 
2.4 Discussion 
 We conducted a meta-analysis quantifying the effect of exercise training on muscular and 
cardiorespiratory fitness outcomes in RCTs of persons with MS. Overall, exercise training 
improved muscular fitness by 0.27 standard deviations, whereas it improved cardiorespiratory 
fitness by 0.47 standard deviations. The mean effect for muscular strength translated into 
increases of 14.15 and 6.69 Nm for knee extensor and flexor peak torque, respectively, or 
approximately a 10% improvement in strength. The mean effect for cardiorespiratory fitness 
translated into an improvement of 3.41 ml/kg/min or 18% in VO2peak. These findings extend 
previous data from systematic reviews on the benefits of exercise training in persons with MS by 
providing estimates of the magnitude of improvement in muscular and cardiorespiratory fitness 
outcomes following exercise training.12 Such data are important for informing future research 
and clinical practice by providing an estimate of the actual benefit of exercise training on 
physical fitness in persons with MS. The Ess, for example, can inform power analyses for 
designing future RCTs, and provide clinicians with an evidence-based estimate of the expected 
improvement in fitness with exercise training in MS patients. 
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Muscular Fitness 
 Muscular fitness is critical in MS for maintaining functional mobility and independence, 
and persons with MS demonstrate relative muscle weakness compared with controls and across 
the range of disability status.5,6 This supports interest in quantifying the effect of exercise 
training on muscular fitness outcomes in MS. Overall, the effect of exercise training on muscular 
fitness was statistically significant, but small in magnitude. Eleven of the fourteen studies (i.e., 
78%) had Ess that were greater than zero, suggesting a generally positive effect of exercise 
training on muscular fitness. We examined the clinical meaningfulness of the effect of exercise 
training on muscular fitness by determining the percent change using previously published data 
in MS. The Ess translated into changes for muscular fitness outcomes involving the knee 
extensors and flexors of 9.5% and 11.6%, respectively. Such changes might reflect clinically 
meaningful improvements that translate into secondary benefits for persons with MS. Indeed, 
muscular fitness has been associated with walking speed and endurance, gait outcomes, cognitive 
processing speed, and fatigue in persons with MS.44 Further, exercise-training interventions that 
improve muscular fitness in those with MS have also resulted in improved mobility, quality of 
life, and fatigue.46 We identified type of outcome measure as a significant moderator of the effect 
of exercise training on muscular fitness outcomes, where muscular strength outcomes yielded a 
larger effect than muscular endurance outcomes. Overall, exercise training is beneficial for 
improving muscular fitness in persons with MS, and researchers and clinicians can expect an 
average change of approximately ⅓ SD.  
Cardiorespiratory Fitness 
 Cardiorespiratory fitness is important for maintaining physical function, body 
composition, and cardiovascular health and it has been reported that persons with MS have lower 
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levels of cardiorespiratory fitness compared to healthy, age-matched controls.5,8 This supports 
interest in quantifying the effect of exercise training on cardiorespiratory fitness in MS. The 
overall effect of exercise training on cardiorespiratory fitness was statistically significant and 
moderate in magnitude. Importantly, nine of the ten studies (i.e., 90%) had Ess that were greater 
than zero suggesting a consistent, positive effect of exercise training on cardiorespiratory fitness 
in MS. The average percent change for cardiorespiratory fitness was 17.7%, and this achieves a 
clinically meaningful change according to previously established criteria that suggest an increase 
of 10% in VO2peak or more to be meaningful.
45 There are important potential secondary benefits 
of improving cardiorespiratory capacity for persons with MS. Cardiorespiratory fitness has been 
associated with cortical plasticity, grey and white matter integrity, walking performance, 
cognition, and fatigue in MS samples.5,44,47-49  Improvements in cardiorespiratory fitness might 
further reduce the risk of cardiovascular comorbidities, as higher levels of subclinical 
atherosclerosis have been reported in persons with MS.50 There were no statistically significant 
moderators of the effect of exercise training on cardiorespiratory fitness; however, the presence 
of exercise supervision approached statistical significance (p=0.06) as a moderator variable. This 
might reflect the high number of studies that involved supervised exercise training (i.e., 80%) 
and included cardiorespiratory fitness outcomes. Exercise training interventions that are 
supervised likely enhance adherence with the exercise prescription, and this would increase the 
likelihood for positive training adaptations.  Overall, we determined that exercise training is 
beneficial for improving cardiorespiratory fitness in persons with MS, and researchers and 
clinicians can expect an average change of approximately ½ SD or 18% following exercise 
training.    
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Muscular vs. Cardiorespiratory Fitness Effect 
 The effect of exercise training on muscular fitness was approximately 0.20 SD units 
smaller than the effect on cardiorespiratory fitness and there was no overlap of point-estimates 
and 95% Cis for Ess. Such results suggest a considerably stronger effect of exercise training on 
cardiorespiratory fitness than muscular outcomes. Importantly, this information is novel in that 
we provide a direct comparison of the effect of exercise training on fitness outcomes through 
meta-analytic procedures. One potential reason for differential effects of exercise training on 
fitness outcomes might be related to the assessment of physical fitness. There was considerable 
variability in the type and quality of measures used to assess muscular fitness (e.g., peak force, 
peak torque, manual muscle test, maximum number of repetitions, etc.), compared to 
cardiorespiratory fitness (i.e., primarily VO2peak and Wp). These measurement issues might have 
contributed to greater inconsistencies in the assessment of muscular strength, and therefore, a 
smaller overall effect of exercise training. Another factor that might have contributed to different 
effects of exercise training on muscular and cardiorespiratory fitness was the prescription of 
exercise training. Aerobic exercise was prescribed either independently or in combination with 
other modalities in the majority of studies reviewed (n = 15). Based on the specificity principle 
of exercise training we would expect greater adaptations in cardiorespiratory fitness since most 
studies involved an aerobic training component. 
 
 
Comparison with Meta-analyses of Other Outcomes 
 There are several meta-analyses that have quantified the effect of exercise training on 
other outcomes that are important for persons with MS. Previous meta-analyses have reported 
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positive effects of exercise training on quality of life (g = 0.23), mobility (g = 0.19), depressive 
symptoms (g = 0.36), and fatigue (g = 0.45).14-17 The effect of exercise training on muscular 
fitness (g = 0.27) was within the mid-range of previously reported effects on other outcomes, 
whereas the effect on cardiorespiratory fitness (g = 0.47) was larger than all of the previously 
reported effects. It was expected that exercise training would have a positive effect on 
physiological fitness outcomes, considering previous research on exercise training in MS, and 
fitness representing a direct consequence of exercise training. Collectively, the evidence from 
previous and current meta-analysis supports the beneficial effects of exercise training from 
fitness through participatory outcomes for people with MS. 
 
2.5 Study Limitations 
 There are several limitations of the current literature involving exercise training in 
persons with MS. A primary limitation was that not all studies included an assessment of 
physical fitness, and therefore, these studies could not be included in this review. We believe that 
fitness measures should become a standard outcome of exercise training studies for quantifying 
fitness benefits as well as understanding the importance of fitness adaptations for other 
outcomes. There was some variability in the quality of tools used to quantify physical fitness 
(e.g., manual muscle testing using a hand-held dynamometer vs. isokinetic dynamometer 
machine), and this might have influenced the precision and accuracy of the overall point-
estimates. Future researchers might consider optimizing the measurement of fitness outcomes in 
future RCTs by using gold standard assessments. Another limitation of the literature is that most 
studies of exercise training have not included individuals with MS with more severe mobility 
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impairment. This limits the generalizability of these findings to persons with mild to moderate 
disability.   
The 20 studies included in this meta-analysis were scored for quality using the 
Physiotherapy Evidence Database (PEDro) scale which ranges between 0 (lowest possible 
quality) and 10 (highest possible quality). A score of 6 on the PEDro scale has previously been 
established as the cut point for high-quality studies. All 20 studies scored 6 points or higher on 
the PEDro scale indicating good overall quality of the RCTs reviewed. Reasons for missing 
points on the PEDro scale commonly included failure to conceal allocation, failure to blind 
subjects or assessors, failure to retain participants, and failure to complete intention-to-treat 
analyses. These shortcomings should be addressed in future studies of exercise training in 
persons with MS to improve the quality of current research in this field. 
 
Limitations of the Meta Analysis  
 There are several limitations that should be considered when interpreting the results of 
this meta-analysis. The primary limitation of this study was that we only included RCTs. The 
inclusion of only RCTs resulted in high quality data, however, we might have failed to include 
valuable information from non-RCTs. This meta-analysis did not examine variability in exercise 
training modalities and other characteristics such as frequency, intensity, and duration of 
training. This was challenging based on the limited number of RCTs that have examined exercise 
training in persons with MS. It is also possible that this analysis is missing other important 
moderator variables that could influence the magnitude of the effect of exercise training on 
physical fitness.     
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2.6 Conclusion 
 We conducted a meta-analysis of RCTs involving persons with MS that examined the 
effect of exercise training on muscular and cardiorespiratory fitness outcomes. Exercise training 
was associated with changes in muscular (small in magnitude) and cardiorespiratory (moderate 
in magnitude) fitness outcomes that approximated a 10% and 18% improvement, respectively. 
Subsequent research might examine the effect of improvements in muscular and 
cardiorespiratory fitness on brain structure, functions such as walking and cognition, and 
symptoms such as depression and fatigue in MS. Researchers can rely on the point estimates 
provided in this paper when designing clinical trials involving exercise training, and clinicians 
can provide a better estimate of actual improvements in fitness when developing exercise 
prescriptions for patients with MS.   
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Chapter 3 
 
Physical fitness is associated with improved arterial function in persons with MS 
 
 
Matthew Platta, Lara Pilutti, Brandon Kistler, Michelle Stratton, Kenneth Wilund, Rob Motl 
 
 
3.1 Introduction 
 Multiple sclerosis (MS) is an immune-mediated disease characterized by inflammation, 
demyelination, and axonal loss within the central nervous system (CNS).1 MS is one of the most 
prevalent neurological diseases affecting 1 out of 1,000 adults in the United States.2 Progressive 
inflammatory attacks within the CNS cause structural damage and transection of axons. Further, 
neurodegenerative processes result in axo-neuronal loss over the later course of the disease. This 
damage results in life-altering functional consequences which can be accompanied by 
cardiovascular comorbidity.      
 There is evidence for cardiovascular dysfunction in persons with MS. Previous research 
indicates decreased arterial function and increased markers of subclinical atherosclerosis in 
persons with MS compared to healthy controls3. For instance, one study reported decreased 
carotid arterial compliance and pulse wave velocity in 33 persons with MS compared to 33 
healthy adults.3 Autonomic dysfunction, as it affects the heart and circulatory function, can 
accompany cardiovascular dysfunction in persons with MS as well leading to impaired blood 
pressure variability and heart rate variability4. Cardiovascular comorbidities such as diabetes, 
hypertension, hypercholesterolemia, peripheral vascular disease are common in persons with MS 
and significantly increase the risk of disability progression.  
 Cardiorespiratory fitness (CRF) is one of the largest influencers of CV function in 
healthy people and when increased, can improve cardiovascular risk factors like insulin 
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sensitivity, decreases in fat mass, decreased markers of inflammation, and lower plasma 
triglycerides.5,6 CRF refers to the body’s ability to deliver, extract, and utilize oxygen for 
endurance exercise and is usually measured as peak aerobic capacity (VO2peak) and peak power 
output (Wp). Muscular fitness (MF) which refers to the body’s ability to generate and maintain 
muscular force via skeletal muscle contraction and is usually measured as muscular strength 
(e.g., peak force) and endurance (e.g., maximum repetitions) and has also been related to an 
improved risk factor profile. CRF and MF are impaired in persons with MS. In a study 
comparing CRF in 37 MS patients and 26 healthy controls VO2peak was demonstrated to be 28% 
lower in the MS sample.7 Another study comparing MF in 15 MS patients and 15 healthy 
controls demonstrated lower peak torque production in knee flexors and extensors in persons 
with MS compared to healthy controls.8   
 In MS, deconditioning that accompanies disease progression, is associated with a loss of 
physiological fitness involving both CRF and MF. This loss of fitness in turn can further demote 
cardiovascular function and may contribute to both disability progression and increased risk of 
CVD9. The relationship between CV function and fitness has been well examined in healthy 
people. CRF has been inversely related with arterial stiffness measures in a sample of 405 young 
men and women.10 Further, CRF is commonly associated with reductions in blood pressure, and 
improvements in cardiac output and circulatory vasodilation.11,12,13 MF has been inversely related 
to arterial stiffness, positively related to compliance, and has been shown to modestly improve 
blood pressure.14 CRF and MF have also been associated with a decreased risk for comorbidities 
such as metabolic syndrome, obesity and CVD in healthy populations.15,16 Although evidence 
exists for CRF and MF having a positive relationship with CV function in healthy people, the 
relationships between CRF, MF and CV function in MS have not been determined. 15,17  
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 We examined the cross-sectional association between physiological fitness (CRF and 
MF) and CV function in a cohort of patients with MS. We hypothesized that both CRF and MF 
will be associated with CV function similar to research conducted in healthy people. This study 
will provide insight into the relationship between fitness and cardiovascular function in this 
clinical population and help identify targets for therapeutic intervention to promote 
cardiovascular function and a reduce comorbid disease risk in persons with MS.    
 
3.2 Methods 
Participants 
Participants were recruited from the North American Research Committee on Multiple Sclerosis 
registry and from a database of participants from previous studies in our laboratory. Healthy 
controls were recruited from the local community. Criteria for inclusion were: 18-64 years old; 
relapse free for the last 30 days; Expanded Disability Status Scale (EDSS) <8.0; able to visit our 
laboratory for testing; minimal risk for engaging in physical activity based on the Physical 
Activity Readiness Questionnaire; physician’s approval for participation and physician 
confirmation of MS diagnosis.18 We made contact with 128 persons of which 86 were screen for 
inclusion. 25 individuals qualified, but were uninterested in participation and 4 individuals did 
not meet inclusion criteria. The final sample included 57 participants with MS.    
EDSS 
Disability status was determined by EDSS (28 from main paper)* examination by Neurostatus-
certified assessors.  
Brachial blood pressure 
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Following 10 minutes of quiet rest in a supine position, participants’ resting systolic (SBP) and 
diastolic (DBP) blood pressures were taken at the brachial artery with an automated oscillometric 
cuff (HEM-907XL; Omron Corporation, Kyoto, Japan). Blood pressure measurements were 
taken in duplicate and averaged. When the recordings were not within 5 mmHg an additional 
measurement was taken.  
Cardiovascular function 
Measures of cardiovascular function was collected in the supine position following 10 minutes of 
quiet rest. Applanation tonometry was performed using a high-fidelity strain gauge transducer 
(SphygmoCor, AtCor Medical, Sydney, Australia) on the right radial artery to obtain pressure 
waveforms. A central aortic pressure waveform was reconstructed from the radial artery pressure 
waveform using a generalized validated transfer function.59 Aortic pulse pressure will be 
calculated by subtracting the aortic diastolic blood pressure (DBP) from the aortic systolic blood 
pressure (SBP). Central pulse wave velocity (cPWV) was calculated from the waveform at the 
right common carotid artery and right femoral artery using the same strain gauge transducer. HR 
was obtained simultaneously using a three-lead CM5 configuration. The distance in millimeters 
from the carotid artery to the suprasternal notch, and the suprasternal notch to the femoral artery 
was measured with a measuring tape. The carotid-suprasternal distance was subtracted from the 
suprasternal-femoral distance to account for differences in the direction of pulse wave 
propagation. cPWV will be calculated from the distances between measurement sites and the 
measured time delay between the proximal and distal waveforms. 
Cardiorespiratory Fitness    
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We determined cardiorespiratory fitness (VO2peak) using an incremental exercise test on a 
recumbent stepper (Nustep T5XR recumbent stepper, Nustep Inc., Ann Arbor, MI). Expired gases 
were collected using a two-way non rebreathable valve (Hans Rudolph Inc., Shawnee, KS) and 
oxygen consumption was measured using an open circuit spirometry system (TrueOne 2400, 
Parvo Medics, Sandy, UT). Participants performed a  one minute warm-up at 15W . The 
resistance on the stepper was then gradually increased until the participant reached volitional 
fatigue. The intensity was increased by 10W/minute for participants with mild-to-moderate MS 
(EDSS 1.0-5.5) and 5W/minute for participants with severe MS (EDSS 6.0). Heart rate (Polar 
Electro Oy, Kempele, Finland) and rating of perceived exertion (RPE) were recorded each 
minute of the test. VO2peak was expressed as ml/kg/min, with 20 second averaging. Criteria for 
VO2peak involved at least one of the following: (1) respiratory exchange ratio ≥1.10; (2) heart rate 
within 10 beats/minute of age-predicted maximum; or (3) RPE ≥17. 
Muscular Fitness 
Muscular strength was assessed bilaterally as peak torque of the knee extensors (KE) and flexors 
(KF) using an isokinetic muscle dynamometer (Biodex System 3 Dynamometer, Biodex Medical 
Systems, Inc., Shirley, NY). Participants performed three, 5 second maximal KE and one 5 
second maximal KF at 60° and 90° flexed. A rest period of 5s was given between each attempt. 
Peak isometric strength was expressed in N∙m and determined as the highest recorded value for 
each muscle group.                 
Data analysis 
Data were analyzed using SPSS Version 22.0 (SPSS Inc., Chicago, IL). Values in the text are 
presented as mean (SD), unless otherwise noted. Participant characteristics were summarized 
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using descriptive statistics. We examined the relationship between CRF or MF and CV function 
measures using bivariate Pearson correlations (r). Statistical significance was set at p <.05.  
3.3 Results 
CRF 
Participant characteristics are presented in Table 4. Correlation coefficients are presented in table 
5.  Aortic pulse pressure (mmHg) was significantly correlated with relative VO2 peak (r = -.288, 
p = .033) and peak power (r = -.268, p = .046). Augmentation pressure (mmHg) was significantly 
correlated with relative VO2 peak (r = -.393, p = .003) and peak power (r = -.375, p = .004). 
Aortic transit time (msec) was significantly correlated with relative VO2 peak (r = .545, p < .001) 
and peak power output (r = .537, p < .001). Aix (%) was significantly correlated with relative 
VO2 peak (r = -.502, p = .002) and peak power (r = -.447, p = .001). Aix at 75 bpm (%) was 
significantly correlated with relative VO2 peak (r = -.624, p < .001) and peak power (r = .561, p 
< .001). SEVR was significantly correlated with relative VO2 peak (r = .290, p = 0.32) but not 
peak power. End systolic pressure (mmHg) was significantly correlated with relative VO2 peak (r 
= -.312, p = .021) but not peak power. Pulse wave velocity was not related to relative VO2 peak 
or peak power. 
MF 
Aortic pulse pressure (mmHg) was significantly correlated with extensor (r = -.346, p = .008) 
and flexor (r = -.347, p = .008) strength (Nm). Augmentation pressure (mmHg) was significantly 
correlated to extensor (r = -.346, p < .001) and flexor (r = -.464, p < .001) strength. Aortic transit 
time (msec) was significantly correlated with extensor (r = .601, p < .001) and flexor (r = .591, p 
< .001) strength. Aix (%) was significantly correlated with extensor (r = -.497, p < .001) and 
flexor (r = -.529, p < .001) strength. Aix at 75 bpm (%) was significantly correlated with 
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extensor (r = -.556, p < .001) and flexor (r = -.575, p < .001) strength. Pulse wave velocity (m·s-
1) was significantly correlated with flexor (r = .297, p = .040) but not extensor strength.  
3.4 Discussion 
We conducted a cross sectional analysis examining the relationships between fitness (CRF and 
MF) and arterial function in persons with MS of varying disability level. The main findings 
indicate that CRF and MF maintain significant relationships with CV function in persons with 
MS, including measures of arterial function and cardiac function. These findings are consistent 
with the previously mentioned hypothesis that CRF and MF are associative of better arterial 
function in persons with MS. Further, these relationships provide therapeutic targets to promote 
better cardiovascular health in MS by improving CRF and MF.     
CRF 
VO2 peak and peak power were significantly correlated with aortic PP, augmentation pressure, 
aortic transit time, and augmentation index. These findings indicate CRF is significantly 
associated with cardiovascular function in MS. Specifically, arterial stiffness and pressure 
aspects of the aortic waveform were found inversely related to CRF. This supports previous 
research on the relationship between CRF, arterial function, and cardiovascular morbidities in 
heathy people.19 SEVR and EDP were significantly correlated with relative VO2 peak, but not 
with PPO suggesting VO2 peak is more strongly related to cardiac perfusion and aortic waveform 
pressures at the of systole than PPO. VO2 peak is the gold standard measure of CRF and is a 
direct indicator of cardiovascular function which would explain its stronger correlations with 
arterial function outcomes.20 PWV, the primary measure of arterial stiffness was not related to 
CRF or PPO. This is contrary to previous evidence on the relationship between VO2 peak and 
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arterial stiffness in healthy populations10. Previous research has found young persons with MS to 
have compromised arterial stiffness. The relationship between MS and artieral stiffness may be 
less moderated by physical fitness than we have presumed do to disease symptoms such as 
inflammation and progression of MS.21 
 Improvements in CRF have long been associated with improved function within the 
cardiovascular system. In MS, increasing disability and lower levels of physical activity are 
responsible for decreasing fitness, which in turn, can affect arterial function and increase the 
likelihood of disease progression, comorbidity, and subsequently further disability. By 
augmenting CRF, this cycle of degenerating function and disability may be altered. In summary, 
CRF has a significant relationships to arterial and cardiac function. Through augmentations to 
CRF via exercise interventions, persons with MS may be able to improve their CV health and 
CV risk profile. 
MF 
Peak extensor torque (Nm) and flexor torque (Nm) were significantly correlated with 
aortic PP, augmentation pressure, aortic transit time, and augmentation index. These findings 
indicate MF to be significantly associated with cardiovascular function in MS. Similar to CRF, 
an inverse relationship exists between pressure aspects of the waveform, arterial stiffness, and 
MF. Along with this, PWV, the best marker for arterial stiffness, was positively correlated with 
flexor peak torque supporting previous evidence that MF is negatively associated with arterial 
stiffness.17 Neither SEVR nor EDP were significantly associated with MF outcomes suggesting 
MF is not strongly related to cardiac perfusion or end systolic pressure in persons with MS. 
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Conflicting evidence exists regarding the relationship between MF and CV function. More recent 
evidence suggests a positive relationship exists between MF and CV function.10,17   Resistance 
training (RT) has also been suggested for metabolic, blood pressure, and musculoskeletal 
improvements.14 RT has also been shown to improve muscular fitness (citations from Rob/Lara 
review), balance, ambulation, and fatigue in persons with MS. These additional benefits along 
with improvements in muscular fitness suggest RT to have a potential effect on cardiovascular 
health in MS albeit less than aerobic exercise. Future research should continue to determine the 
effects of RT on cardiovascular function in MS persons in order to further clarify this.  
3.5 Study Limitations 
Limitations of this cross sectional study involving fitness and CV function in MS also 
exist. First, this study is a cross sectional study and fails to establish cause and effect 
relationships between fitness and CV function in MS.  Therefore, it is recommend that future 
research should examine the effect of exercise training on fitness and CV function using a RCT 
design to establish cause and effect. Second, this sample involved persons with varying levels of 
disability of MS. The difference in disability level can influence fitness and CV function and 
makes generalizability of this study more difficult. Another limitation involves this CV measures 
taking recordings as a result of mathematical algorithms instead of direct measurement of fluid 
dynamics within the cardiovascular system. This CV measurements have been well validated in 
healthy people but may suffer precision as opposed to more invasive measurements of CV 
function.22,23   Although participants were asked to control their diet via fasting there have no 
guarantee that CV outcomes were not influenced by nutrition or ingestion of drugs such as 
caffeine and nicotine prior to assessments. Lastly, since CV measures for men were taken by a 
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male researcher and women were taken by a female researcher, inter-tester reliability may be a 
limitation. 
3.6 Conclusion 
In this study, the relationship between fitness and CV function in persons with MS of varying 
disability was examined. It can be concluded that both CRF and MF are correlated with better 
CV function in persons with MS. Relative to CRF, this result is not surprising, and  supports to 
the concept that improving CRF might improve CV function in persons with MS. The best way 
to achieve these adaptations are through aerobic exercise training which has numerous 
established benefits for persons with MS. Further research, including intervention studies, should 
be conducted in order to determine the effects of aerobic training on CV function in persons with 
MS. MF was also positively correlated with both pressure outcomes and arterial stiffness. With 
more recent evidence confirming better CV function to be related to better MF, further research 
should be conducted to determine the effect of resistance training on CV function in persons with 
MS. In summary, CRF and MF are associated with better CV function in persons with MS and 
augmenting fitness with aerobic and/or resistance training may be a viable therapy to improve 
CV function and comorbidity in persons with MS.              
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Chapter 4 
Discussion 
 This thesis describes the relationships between multiple sclerosis (MS), physiological 
fitness, cardiovascular (CV) function, and exercise. First a meta-analyses was used to determine 
the magnitude of effect of exercise training on cardiorespiratory fitness (CRF) and muscular 
fitness (MF). The purpose of this meta-analyses was help clarify the efficacy of exercise training 
programs on CRF and MF in persons with MS. Without this systematic quantification of studies 
using exercise as an intervention effects, it would be difficult to determine whether or not 
benefits of exercise that have been shown to occur with training in MS are resultant of the 
physiological adaptations to fitness that come with aerobic and resistance training. It is important 
to determine if fitness adaptations can be expected to accompany MS related benefits following 
exercise training. Secondly, a cross sectional design was used to examine the relationship 
between CRF, MF and CV function in persons with MS. Arterial function in MS is not 
thoroughly examined and its relationship with physiological fitness has not been described in this 
clinical population. It is important for determining the potential efficacy that improving CRF and 
MF, through exercise intervention, can have on persons with MS. Overall, the results of these 
two studies have provided clinically relevant information that can help the development of future 
research protocols and applied exercise programming involving persons with MS. 
The meta-analyses examined 20 randomized controlled trials (RCTS) of which 63 effects 
sizes (ES) were calculated. These 20 studies were rated for quality according to the 
Physiotherapy Evidence Database Scale (PEDro) scale involves a checklist of 10 scale allowing 
for assessment of low quality (1) and high quality (10) criteria within each study. Failure to 
conceal allocation, failure to blind subjects or assessors, failure to retain participants, and failure 
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to complete intention-to-treat analyses are common methodological failures for which points are 
deducted from RCTs. A score of 6 has been previously established as the cut point for high 
quality RCT’s of which all 20 RCT’s in this meta-analyses achieved.1 Therefore, the results of 
this analysis are drawn from studies of higher methodical quality. 
Of the fourteen studies with MF measures, eleven showed a positive effect of exercise 
training on MF. For MF outcomes, the overall mean ES was 0.27 (SE=0.05, 95% CI=0.17-0.38, 
z=5.05, p<.001) suggesting a small but significant effect of exercise training on MF outcomes. 
Of the ten studies with CRF measures, nine showed a positive effect of exercise training on CRF. 
For CRF outcomes, the overall mean ES was 0.47 (SE=0.09, 95% CI=0.30-0.65, z=5.40, p<.001) 
suggesting a moderate and significant effect of exercise training on CRF.   
The results were quantified into a clinically meaningful metric for both CRF and MF. 
The ESs for VO2peak, (SD = 7.25), peak knee extensor, and flexor torque (Nm, SDs = 52.41 and 
24.75, respectively) were multiplied by their SDs resulting an average increase in VO2peak of 3.41 
ml/kg/min or 17.7% change. The improvements for extensor and flexor strength were 14.15 and 
6.69 Nms and their percent changes were 9.5% and 11.6% respectively. Overall, the 
improvements calculated are not substantial nor minimal. CRF improvements above 10% change 
in VO2peak have been deemed clinically relevant previously.
2 Participants analyzed achieved an 
average improvement to CRF well above this threshold indicating aerobic exercise training to be 
a clinically relevant intervention for achieving improvements in CRF in MS. Improvements to 
muscular fitness were approximately 10% for both extensors and flexors. Even small 
improvements in muscular fitness can have clinically relevant effects on mobility and stability in 
MS and these improvements indicate the efficacy of resistance training for improving MF in MS. 
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In this study, a cross sectional examination of the relationships between cardiovascular 
function, physiological fitness and MS in 57 participants with MS was conducted. Blood 
pressure, arterial function, and arterial stiffness, and cardiac perfusion were measured. Fitness 
measures included a VO2peak test on a recumbent stepper and max strength test on an isokinetic 
dynamometer. The main finding of this cross sectional analysis indicate the CRF and MF are 
positively correlated with better arterial function in persons with MS. These relationships have 
not been thoroughly examined in MS and are novel since they provide a potential therapeutic 
target to promote cardiovascular health in MS. Since aerobic and resistance training have each 
been shown to benefit persons with MS it would further highlight them as possible interventions 
for another important health factor such as cardiovascular health. 
Cardiorespiratory fitness measures including relative VO2peak and peak power output 
(PPO) were significantly correlated with aortic pulse pressure, augmentation pressure, aortic 
transit time, and augmentation index. According to the finding that CRF is related to better 
arterial functioning it can be concluded that CRF is a predictor of these outcomes. Both arterial 
stiffness and pressure aspects of the aortic waveform were found to be better in MS patients with 
better CRF. Further, Subendocardial viability ratio (SEVR) and end diastolic pressure (EDP) 
were significantly correlated with relative VO2peak but not PPO suggesting VO2peak is a better 
predictor of cardiac perfusion and aortic pressures than PPO. This is understandable since 
VO2peak is known as the gold standard for CRF assessment and is a direct indicator of CV 
function. While significantly correlations occurred between CRF and many CV outcomes, the 
gold standard for arterial stiffness, pulse wave analysis (PWV) was not found to be significantly 
related to CRF. The explanation for this is lacking as a previous cross sectional examination of 
CV function in healthy populations showed an indirect relationship between VO2peak and arterial 
 61 
 
stiffness.3 As mentioned, CRF is a well-established indicator of CV function in healthy people. 
MS diagnosis is eventually accompanied by increasing disability and decreasing PA along with 
physiological deconditioning which further decrease CRF. These effects on CRF then can in turn 
affect CV function, promoting a more chronically stressed CV system and may lead to increases 
in disease progression and comorbidity or even CVD. This research illustrates the importance of 
CRF in preventing this downward progression involving MS and CV health. 
MF was also found to be related to CV function in MS. Specifically, extensor peak torque 
and flexor peak torque were each significantly correlated with aortic pulse pressure, 
augmentation pressure, aortic transit time, and augmentation index. These results suggest MF is 
also a predictor of CV function in persons with MS. However, MF was also significantly 
correlated with arterial stiffness in the PWV measures indicating MF is negatively associated 
predictor of arterial stiffness in MS. In contrast to CRF, MF was not found to have positive 
correlations with SEVR or EDP suggesting MF is not a good predictor of cardiac perfusion or 
pressures at the end of diastole in persons with MS. The relationship between MF and CV 
function has been difficult as there is conflicting evidence available. More recent research has 
suggested no relationship or a positive relationship exists between MF and CV function.4,5,6,7 
Better MF may be responsible for lessening the cardiovascular burden by affecting risk factors 
(such as BP, HDL, body fat, inflammation, insulin sensitivity, and lean tissue) and therefore may 
reduce risk of CVD.  
These results provide evidence for the strength of the relationships between CRF, MF and 
CV function in persons with MS. These results also support the potential for exercise to improve 
CV function in MS through exercise adaptations. Such adaptations will likely lead to adaptations 
in CV function that have been long established by research done with healthy people following 
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regular exercise training. Such improvements include better insulin sensitivity, decreases in fat 
mass, decreased markers of inflammation, and lower plasma triglycerides 8,9. These can be 
highly influential to overall cardiovascular health and influential to one’s disposition to CVD. 
Improvements to MF that accompany regular resistance training can also have beneficial effects 
on these risk factors as previously mentioned. Further, benefits to cardiovascular health are 
common following regular exercise training in healthy populations but have not been tested in 
persons with MS. 
  These two studies provide evidence of an inherent relationship between fitness and CV 
function in MS. This relationship has been previously established in healthy people and other 
clinical populations but had not been thoroughly examined in persons with MS. Persons with MS 
have been shown to have more CV dysfunction than healthy people and are more prone to 
developing vascular comorbidity also. This results show that physiological fitness (CRF and MF) 
in persons with MS is 1. Augmentable via exercise and 2. A mediator of CV function. This is 
important because exercise has a large body of literature to draw from when attempting to 
determine exercise’s effects on CV function in healthy population. If this evidence is also 
relative to MS in terms of the anticipated adaptations that can be expected from regular exercise 
training then CV function can be improved by adoption of regular exercise in persons with MS. 
The implications of improving CV function can be of great benefit to longevity and maintenance 
of MS and to the prevention of MS disease progression.    
Although the results of this meta-analysis and cross sectional study are pertinent to 
developing options for therapy there remain limitations within this research. When developing a 
meta-analysis a primary limitation found in the literature is the failure by researchers to 
effectively measure physiological fitness or not measure it at all. This makes assessing the 
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effects of exercise on fitness impossible for those studies even though they may have used 
exercise as an intervention. These articles are unusable for this analysis. For this reason, it is 
suggested physical fitness measures be implemented in any study that involves an exercise 
training intervention in MS. Standardizing these measures in exercise training studies would 
provide knowledge of exercise training effects on fitness which is directly related to different 
outcomes in MS. Another limitation to the meta-analysis involved the variability of the quality of 
tools used to assess fitness adaptations which may have influenced the precision and accuracy of 
the effects of exercise on CRF and MF. For example, muscle testing assessed via hand held 
dynamometer is not as accurate in comparison to muscle testing assessed via an isokinetic 
dynamometer. For this reason, it is suggested that optimizing measurements of fitness outcomes 
in future studies should be done by using gold standard assessments for determining fitness 
changes following exercise in MS. Another limitations comes from a lack of diversity of severity 
among participants recruited for research. The majority of research has been done with 
participants who have more severe impairment and therefore it’s more difficult to generalize this 
findings across all people with MS. The meta-analysis was also limited by a low number of 
RCTs available for analysis. The 20 studies were considered high quality according to PEDro 
scoring but a larger sample for analysis would strengthen analysis and support overall ES 
calculations. Another limitation was that this meta-analysis did not examine variability in 
exercise training modalities and other characteristics such as frequency, intensity, and duration of 
training. Lastly, it is possible that this analysis failed to determine certain moderator variables 
that could influence the magnitude of the ES that exercise had on fitness.  
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4.1 Limitations 
Limitations of this cross sectional study involving fitness and CV function in MS also 
exist. First, this study is a cross sectional study and fails to establish cause and effect 
relationships between fitness and CV function in MS.  Therefore, it is recommended that future 
research should examine the effect of exercise training on fitness and CV function using a RCT 
design to establish cause and effect. Second, this sample involved persons with varying levels of 
disability of MS. The difference in disability level can influence fitness and CV function and 
makes generalizability of this study more difficult. Another limitation involves this CV measures 
taking recordings as a result of mathematical algorithms instead of direct measurement of fluid 
dynamics within the cardiovascular system. This CV measurements have been well validated in 
healthy people but may suffer precision as opposed to more invasive measurements of CV 
function.10,11   Although participants were asked to control their diet via fasting there is no 
guarantee that CV outcomes were not influenced by nutrition or ingestion of drugs such as 
caffeine and nicotine prior to assessments. Lastly, since CV measures for men were taken by a 
male researcher and women were taken by a female researcher, inter-tester reliability may be a 
limitation. 
 
4.2 Future Directions 
Future research is needed to continue to elucidate the relationships between MS, 
physiological fitness and CV function and exercise. Differences in MS functionality that 
manifest externally become quite clear with disease progression but less obvious changes to 
other internal body system functions and their potential impairment, such as CV impairment, are 
equally important to address. CV function is addressed clinically and through research in healthy 
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populations and other clinical populations consistently but has received less attention in those 
with MS. In order to address and adequately treat physiological changes that occur with MS, is it 
important to determine the relationships between CV function and physiological fitness in MS 
and how this relationship impacts CV outcomes among other health outcomes followed regular 
exercise training. Future RCTs could aim to determine this with a carefully designed study 
utilizing aerobic exercise and taking CV function measures such as arterial stiffness, arterial 
wave reflection, and measuring morphological change like intima media thickness. Evidence 
provided by this meta-analyses and cross sectional examination is the foundation for developing 
these future protocols. With further evidence corroborating these relationships researchers and 
clinicians can be confident in designing exercise programming that benefits persons with MS in 
order to achieve the previously established benefits exercise has on MS as well as potential CV 
benefits.  
 
4.3 Conclusion 
The extent of this literature review and discussion provide an analysis of evidence 
regarding the relationships between MS, physiological fitness, CV function, and exercise. 
Overall, this research suggests exercise training interventions have an effect on CRF and MF in 
persons with MS. Further, it is determined that significant relationships exist between both CRF 
and MF and CV function in persons with MS. These relationships indicate an inverse 
relationship exists between fitness and CV function and provides insight to physiological fitness 
being a potential target of therapy that could result in CV benefits and improved cardiovascular 
risk profiles in persons with MS. This conclusion supports previous evidence on the efficacy of 
exercise training for functional benefits in MS. However, a little evidence exists on the topic of 
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fitness and CV function in persons with MS it is important that future researchers examine cause 
and effect relationships that may exist between exercise training and CV function in MS patients. 
This can be achieved via RCTs using this cross sectional study as a foundation for protocol 
development.      
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Chapter 5 
Figures and Tables 
Figure 1.  Flow diagram of study selection. 
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Reasons for exclusion: no MS 
patients; duplicates; reviews or 
meta-analyses; no exercise 
training 
 
Articles reviewed in detail 
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randomized controlled trial; 
intervention-based control 
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low quality fitness outcomes 
 
Randomized controlled trials 
included for analysis 
n = 20 
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Figure 2.  Average effect size, standard errors, and upper and lower limit of effects from 14 studies included in the muscular fitness 
outcomes meta-analyses. CI = confidence interval. 
 
 
 
 
 
 
 
 
 
 
 
Study name Subgroup within study Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error limit limit
Sosnoff et al. combined/ isometric KE (kg) -0.22 0.43 -1.07 0.62
Nilsagard et al. exercise group/timed chair stands -0.08 0.22 -0.52 0.35
Harvey et al. Combined -0.02 0.29 -0.59 0.56
Skjerbaeck et al. handgrip exercise 0.02 0.63 -1.22 1.26
Petajan et al. Combined 0.24 0.09 0.07 0.41
Medina-Perez et al. Combined 0.26 0.17 -0.08 0.59
Dalgas et al. KE MVC (Nm) 0.27 0.36 -0.43 0.98
Dalgas et al Combined 0.35 0.18 -0.00 0.71
Broekmans et al. Combined 0.37 0.17 0.03 0.71
Debolt et al. Leg Ext(power in W/kg and power in W) 0.40 0.34 -0.26 1.06
Surakka et al. Combined 0.40 0.15 0.11 0.69
Fimland et al. max strength training (Nm) 0.69 0.55 -0.39 1.76
Golzari et al. yoga/digital instrument (strength in kg's) 1.15 0.48 0.21 2.10
Learmonth et al. MMT weakest quadriceps strength (Nm) 1.32 1.28 -1.19 3.84
0.27 0.05 0.17 0.38
-2.00 -1.00 0.00 1.00 2.00
                                                 Favorable effect of strength training
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Figure 3.  Average effect size, standard errors, and upper and lower limit of effects from 10 studies included in the cardiorespiratory 
fitness outcomes meta-analyses. CI = confidence interval. 
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TABLES 
TABLE 1. Study quality, sample size, number, average and range of effect sizes for muscular and cardiorespiratory fitness, and training mode for 
the 20 studies included in the meta-analysis. 
 
   Muscular Cardiorespiratory     
Ref # PEDro 
Score 
n # of 
Effects 
Average Effect 
(range) 
# of 
Effects 
Average Effect 
(range) 
Mode Time 
(Min) 
Frequency 
(x/Wk) 
Duration 
(Wks) 
2 6 16 0 N/A 3 0.69 (0.65 - 0.77) Combined 60 3 5 
4 7 42 0 N/A 3 0.48 (0.33 - 0.72) Aerobic 14-45 2-3 8-10 
6 7 33 0 N/A 4 0.61 (-0.33 - 1.41) Combined 60 5 20 
8 7 30 0 N/A 1 1.41 Combined 60 3 10 
17 6 20 1 1.10 1 -0.46 Combined 60 3 8 
29 6 25 0 N/A 2 0.61 (0.61) Aerobic 30 5 3-4 
35 7 46 12 0.24 (0.04 – 0.57) 2 0.59 (0.55 - 0.62) Aerobic 40-50 3 15 
45 9 10 0 N/A 1 0.89  Aerobic NR 2-3 4 
44 8 28 0 N/A 1 -0.04 Aerobic 30 2 8 
18 7 23 0 N/A 2 -0.61 (-1.12 - -0.10)  Mixed NR 2-3 24 
28 6 42 4 0.25 (0 – 0.43) 0 N/A Resistance NR 2 12 
5 7 23 6 0.36 (-0.01 – 0.49) 0 N/A Resistance 60 2-3 20 
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10 8 31 4 0.35 ( 0.10 – 0.56) 0 N/A Resistance NR 2 12 
Table 1 (cont.)       
11 7 31 1 0.27 0 N/A Resistance NR 2 12 
12 7 36 1 0.39 0 N/A Resistance NR 3 8 
15 6 14 1 0.64 0 N/A     
19 6 19 4 -0.01 (-0.34 – 0.39) 0 N/A Resistance; 
other 
40 2 6 
25 7 28 1 1.28 0 N/A Combined 60 2 12 
34 7 80 1 -0.08 0 N/A Combined 30 2 6-7 
49 6 95 4 -0.31 (-0.54 -      
-0.74) 
0 N/A Mixed NR 3-5 26 
47 6 22 1 -0.22 0 N/A Aerobic 30 2 8 
           
NR = not reported. 
 
 73 
 
TABLE 2. Muscular outcomes random–effects moderator analysis.* p<.05, **p<.001.  
 
Moderator Type (# of studies) Point estimate (SE) Z –value (p) Qb (df) 
 
 
Program type 
 
Resistance only (3) 
Combined (11) 
 
0.32 (0.15) 
0.27 (0.06) 
 
2.14* 
4.34** 
 
0.10 (1) 
Type of outcome 
measure 
Strength (13) 
Endurance (3) 
0.31 (0.06) 
-0.05 (0.17) 
5.42** 
-0.29 
3.96* (1) 
Type of 
measurement 
device  
Isokinetic (10) 
Other (4) 
0.28 (0.06) 
0.39 (0.38) 
5.03** 
1.03 
0.07 (1) 
Progression 
 
Progression (10) 
No progression (4) 
0.33 (0.07) 
0.21 (0.08) 
4.47** 
2.62* 
1.33 (1) 
Sample size 40 or less (10) 
< 40 participants (4) 
0.33 (0.10) 
0.25 (0.07) 
3.42** 
3.50** 
0.48 (1) 
Supervision Completely supervised 
(10) 
Partially or 
unsupervised (4) 
0.27 (0.06) 
0.28 (0.13) 
4.44** 
2.19* 
 
0.00 (1) 
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TABLE 3.  Cardiorespirtory outcomes random-effects moderator analysis.* p<.05, 
**p<.001.+subgroup as unit of analysis was used. 
 
Moderator Type (# of studies) Point estimate (SE) Z –value (p) Qb (df) 
 
 
Type of 
cardiorespiratory 
outcome measure+ 
 
 
VO2 (10) 
Work (7) 
Other (6) 
 
0.37 (0.14) 
0.50 (0.16) 
0.65 (0.26) 
 
2.72* 
3.11* 
2.49* 
 
1.08 (2) 
Exercise type Aerobic (7) 
Other (3) 
0.50 (0.10) 
0.31 (0.31) 
5.04** 
0.99 
0.32 (1) 
Exercise modality Cycle (5) 
Other (3) 
0.53 (0.11) 
0.10 (0.37) 
5.02** 
0.28 
 
1.27 (1) 
Exercise intensity 
 
Moderate (4) 
High (4) 
0.60 (0.14) 
0.48 (0.13) 
4.40** 
3.80** 
0.50 (1) 
Sample size < 25 participant (7) 
25 or more (4) 
0.49 (0.21) 
0.44 (0.12) 
2.38* 
3.62** 
0.04 (1) 
Supervision Supervised (9) 
Partially or 
unsupervised (2) 
0.55 (0.13) 
0.03 (0.25) 
 
4.43** 
0.10 
 
3.2 (1) 
(p=0.06) 
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Table 4. Participant Characteristics   
 
 MS (n = 57) 
Age (yr) 51.58 (7.99) 
Sex (F/M) 39/18 
Disease type 
(relapsing/progressive) 
43/13 
Height (cm) 170.41 (10.26) 
Weight (kg) 78.74 (20.03) 
Years diagnosed (yr) 13.55 (8.93) 
SBP (mmHg) 121.40 (23.79) 
DBP (mmHg) 75.68 (10.46) 
HR (bpm) 65.07 (10.43) 
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Table 5.  
Correlation coefficients between aerobic capacity and muscular strength in the overall MS sample.  
 
CV outcome Relative VO2 peak 
(ml/kg/min) 
Peak power output (W) Extensors 60° (Nm) Flexors 60° (Nm) 
Aortic PP (mmHg) -.288 (p = .033) -.268 (p = .046) -.346 (p = .008) -.347 (p = .008) 
Augmentation Pressure 
(mmHg) 
-.393 (p = .003) -.375 (p = .004)  -.455 (p < .001) -.464 (p <.001) 
Aortic T1 (msec) .376 (p = .005) .376 (p = .005)  .364 (p = .008) .448 (p < .001) 
Aortic Tr (msec) .545 (p < .001) .537 (p < .001) .601 (p < .001) .591 ( p < .001) 
Aix (%) -.502 (p = .002) -.447 (p = .001) -.497 (p < .001) -.529 (p < .001) 
Aix 75 bpm (%) -.624 (p < .001) -.561 (p <.001) -.556 (p < .001)  -.575 (p < .001) 
SEVR  .290 (p = .032) .223 (p = .099)  .079 (p = .558) .117 (p = .385) 
End systolic pressure 
(mmHg) 
-.312 (p = .021)  -.194 (p = .153) -.237 (p = .076) -.247 (p = .064) 
Pulse wave velocity (m·s-
1) 
.057 (p = .707) .172 (p = .247) .226 (p = .123) .297 (p = .040) 
 
